Liver cirrhosis in Fontan patients does not affect 1-year post-heart transplant mortality or markers of liver function

Keyphrases

• Liver Function 100%
• Liver Cirrhosis 100%
• Heart Transplant 100%
• Fontan Patients 100%
• Cirrhosis 70%
• Computational Imaging 30%
• Non-cirrhotic 30%
• Liver Evaluation 30%
• Liver 10%
• Liver Disease 10%
• Liver Biopsy 10%
• Computed Tomography 10%
• Bridging Fibrosis 10%
• Between-group 10%
• All-cause Mortality 10%
• Patient Survival 10%
• Albumin 10%
• Bilirubin 10%
• Alanine Aminotransferase 10%
• Aspartate Aminotransferase 10%
• Tacrolimus 10%
• 1-year Mortality 10%
• Fontan Procedure 10%
• Non-cirrhosis 10%
• Background Liver 10%
• Heart Transplant Outcomes 10%
• Fontan 10%
• Architectural Change 10%

Medicine and Dentistry

• Liver Cirrhosis 100%
• Heart Graft 100%
• Liver Function 100%
• Computer Assisted Tomography 33%
• Liver Disease 8%
• Liver Biopsy 8%
• Fibrosis 8%
• Bilirubin 8%
• Contraindication 8%
• Tacrolimus 8%
• Alanine Aminotransferase 8%
• Aspartate Aminotransferase 8%
• Fontan Procedure 8%
• All Cause Mortality 8%
• Albumin 8%
• Primary Outcome 8%

Pharmacology, Toxicology and Pharmaceutical Science

• Liver Cirrhosis 100%
• Liver Disease 8%
• Fibrosis 8%
• All Cause Mortality 8%
• Aspartate Aminotransferase 8%
• Alanine Aminotransferase 8%
• Bilirubin 8%
• Tacrolimus 8%
• Albumin 8%